Steven A. Madreperla, MD, PhD
Steven A. Madreperla, MD, PhD
Specialty Practice Area:
Retina Disease & Vitreoretinal Surgery, Oncology
Dr. Steven A. Madreperla joined NJRetina in 1999. He then earned his MD/PhD (Neuroscience) degree from Johns Hopkins University School of Medicine, Baltimore and completed his residency in ophthalmology at the Wilmer Ophthalmological Institute at Johns Hopkins. His fellowship training in vitreoretinal disease and surgery was completed at the Duke University Eye Center, Raleigh, followed by an additional fellowship in Ocular Oncology at the Moorfields Eye Hospital, St. Bartholomew’s Hospital, London.
Dr. Madreperla holds teaching appointments at the Rutgers-New Jersey Medical School. He is on the medical staff of Clara Maass Medical Center, St. Barnabas Medical Center, Hackensack University Medical Center, and the University of Medicine of Dentistry of New Jersey.
Dr. Madreperla has researched, published, and lectured at national and international meetings on numerous topics in ophthalmology, including diabetic retinopathy, macular degeneration, retinoblastoma, choroidal hemangioma, choroidal melanoma, macular hole, and retinitis pigmentosa. Dr. Madreperla has extensive participation as Principal Investigator in a number of multi-center clinical trials for macular degeneration, diabetic macular edema, and retinal vein occlusion.
Dr. Madreperla is the President of NJRetina and the CEO and President of PRISM Vision Group.
Dr. Madreperla is married with two children, and he enjoys golf, fishing, and aviation.
Diseases, Conditions & Procedures: Dr. Madreperla holds teaching appointments at the Rutgers-New Jersey Medical School. He is on the medical staff of Clara Maass Medical Center, St. Barnabas Medical Center, Hackensack University Medical Center, and the University of Medicine of Dentistry of New Jersey.
Dr. Madreperla has researched, published, and lectured at national and international meetings on numerous topics in ophthalmology, including diabetic retinopathy, macular degeneration, retinoblastoma, choroidal hemangioma, choroidal melanoma, macular hole, and retinitis pigmentosa. Dr. Madreperla has extensive participation as Principal Investigator in a number of multi-center clinical trials for macular degeneration, diabetic macular edema, and retinal vein occlusion.
Dr. Madreperla is the President of NJRetina and the CEO and President of PRISM Vision Group.
Dr. Madreperla is married with two children, and he enjoys golf, fishing, and aviation.
Retina Disease & Vitreoretinal Surgery :: Age Related Macular Degeneration (AMD)
Retina Disease & Vitreoretinal Surgery :: Diabetic Retinopathy
Retina Disease & Vitreoretinal Surgery :: Macular Disease
Retina Disease & Vitreoretinal Surgery :: Macular Hole
Retina Disease & Vitreoretinal Surgery :: Cystoid Macular Edema (CME)
Retina Disease & Vitreoretinal Surgery :: Central Serous Chorioretinopathy (CSC)
Retina Disease & Vitreoretinal Surgery :: Retinal Membranes
Retina Disease & Vitreoretinal Surgery :: Diabetic Macular Edema (DME)
Retina Disease & Vitreoretinal Surgery :: Retinal Vascular Disease-RAO/RVO
Retina Disease & Vitreoretinal Surgery :: Peripheral Retinal Degeneration
Retina Disease & Vitreoretinal Surgery :: Retinal Tear
Retina Disease & Vitreoretinal Surgery :: Retinal Detachment
Retina Disease & Vitreoretinal Surgery :: Inherited Retinal Disease
Retina Disease & Vitreoretinal Surgery :: Retinal Infection-Retinitis
Retina Disease & Vitreoretinal Surgery :: Posterior Uveitis
Retina Disease & Vitreoretinal Surgery :: Intraocular Tumors
Retina Disease & Vitreoretinal Surgery :: Ocular Oncology
Retina Disease & Vitreoretinal Surgery :: Ocular Melanoma
Retina Disease & Vitreoretinal Surgery :: Retinoblastoma